128 related articles for article (PubMed ID: 11764987)
1. Quinoids as reactive intermediates in estrogen carcinogenesis.
Bolton JL; Chang M
Adv Exp Med Biol; 2001; 500():497-507. PubMed ID: 11764987
[No Abstract] [Full Text] [Related]
2. Is bisphenol A a weak carcinogen like the natural estrogens and diethylstilbestrol?
Cavalieri EL; Rogan EG
IUBMB Life; 2010 Oct; 62(10):746-51. PubMed ID: 20945454
[TBL] [Abstract][Full Text] [Related]
3. Genotoxic effects of estrogens.
Liehr JG
Mutat Res; 1990 May; 238(3):269-76. PubMed ID: 2160607
[TBL] [Abstract][Full Text] [Related]
4. p-Quinone methides are the major decomposition products of catechol estrogen o-quinones.
Bolton JL; Shen L
Carcinogenesis; 1996 May; 17(5):925-9. PubMed ID: 8640939
[TBL] [Abstract][Full Text] [Related]
5. Quinoids formed from estrogens and antiestrogens.
Bolton JL; Yu L; Thatcher GR
Methods Enzymol; 2004; 378():110-23. PubMed ID: 15038960
[No Abstract] [Full Text] [Related]
6. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture.
Cavalieri E; Rogan E
Ann N Y Acad Sci; 2006 Nov; 1089():286-301. PubMed ID: 17261777
[TBL] [Abstract][Full Text] [Related]
7. Potential mechanisms of estrogen quinone carcinogenesis.
Bolton JL; Thatcher GR
Chem Res Toxicol; 2008 Jan; 21(1):93-101. PubMed ID: 18052105
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA.
Zhang Y; Gaikwad NW; Olson K; Zahid M; Cavalieri EL; Rogan EG
Metabolism; 2007 Jul; 56(7):887-94. PubMed ID: 17570247
[TBL] [Abstract][Full Text] [Related]
9. A unified mechanism in the initiation of cancer.
Cavalieri EL; Rogan EG
Ann N Y Acad Sci; 2002 Apr; 959():341-54. PubMed ID: 11976208
[TBL] [Abstract][Full Text] [Related]
10. Role of quinoids in estrogen carcinogenesis.
Bolton JL; Pisha E; Zhang F; Qiu S
Chem Res Toxicol; 1998 Oct; 11(10):1113-27. PubMed ID: 9778307
[No Abstract] [Full Text] [Related]
11. Initiation of cancer and other diseases by catechol ortho-quinones: a unifying mechanism.
Cavalieri EL; Rogan EG; Chakravarti D
Cell Mol Life Sci; 2002 Apr; 59(4):665-81. PubMed ID: 12022473
[TBL] [Abstract][Full Text] [Related]
12. Endogenous estrogens as carcinogens through metabolic activation.
Yager JD
J Natl Cancer Inst Monogr; 2000; (27):67-73. PubMed ID: 10963620
[TBL] [Abstract][Full Text] [Related]
13. Estrogens as endogenous genotoxic agents--DNA adducts and mutations.
Cavalieri E; Frenkel K; Liehr JG; Rogan E; Roy D
J Natl Cancer Inst Monogr; 2000; (27):75-93. PubMed ID: 10963621
[TBL] [Abstract][Full Text] [Related]
14. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators.
Cavalieri EL; Stack DE; Devanesan PD; Todorovic R; Dwivedy I; Higginbotham S; Johansson SL; Patil KD; Gross ML; Gooden JK; Ramanathan R; Cerny RL; Rogan EG
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10937-42. PubMed ID: 9380738
[TBL] [Abstract][Full Text] [Related]
15. Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer.
Cavalieri EL; Rogan EG
J Steroid Biochem Mol Biol; 2011 Jul; 125(3-5):169-80. PubMed ID: 21397019
[TBL] [Abstract][Full Text] [Related]
16. Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones.
Han X; Liehr JG
Carcinogenesis; 1995 Oct; 16(10):2571-4. PubMed ID: 7586168
[TBL] [Abstract][Full Text] [Related]
17. Microsomal hydroxylation of 2- and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis.
Ashburn SP; Han X; Liehr JG
Mol Pharmacol; 1993 Apr; 43(4):534-41. PubMed ID: 8386306
[TBL] [Abstract][Full Text] [Related]
18. Tyrosinase-catalyzed oxidation of 17beta-estradiol: structure elucidation of the products formed beyond catechol estrogen quinones.
Pezzella A; Lista L; Napolitano A; d'Ischia M
Chem Res Toxicol; 2005 Sep; 18(9):1413-9. PubMed ID: 16167833
[TBL] [Abstract][Full Text] [Related]
19. Impact of metabolism on the safety of estrogen therapy.
Prokai-Tatrai K; Prokai L
Ann N Y Acad Sci; 2005 Jun; 1052():243-57. PubMed ID: 16024767
[TBL] [Abstract][Full Text] [Related]
20. Bioreductive activation of catechol estrogen-ortho-quinones: aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity.
Shen L; Pisha E; Huang Z; Pezzuto JM; Krol E; Alam Z; van Breemen RB; Bolton JL
Carcinogenesis; 1997 May; 18(5):1093-101. PubMed ID: 9163701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
